Abstract
Humans can be exposed to aquatic toxins mainly through contamination of food and water (drinking and recreational). Among these toxins, contamination by both phycotoxins occurring in shellfish and cyanotoxins mostly involved in freshwater bodies are of concern for public health. Whereas regulations exist to evaluate the genotoxicity of most compounds to which humans are exposed, including drugs and chemicals, no regulations have been established for these compounds. In this paper, we show that the same strategy including both in vitro and in vivo tests can be followed to evaluate the genotoxicity of aquatic toxins (phycotoxins and cyanotoxins). However, this strategy encountered different limits which arise when completing an overview of the genotoxic potential of toxins. The most restrictive one is undoubtedly the low amount (even the lack sometimes) of purified toxins available. Solutions and recommendations for testing the genotoxicity of aquatic toxins are suggested to overcome the specific problems encountered with these compounds. It must be kept in mind that recent developments in drug toxicology should be considered and that experiments must be conducted in respect of the 3Rs principle of refinement, reduction and replacement for animal experimentation.
Similar content being viewed by others
References
Botana L (2000) Seafood and freshwater toxins. Pharmacology, physiology and detection. Dekker, New York
Chorus I, Bartram J (1999) Toxic cyanobateria in water. A guide to their public health consequences, monitoring and management. Spon, London
Chorus I (2001) Cyanotoxins. Occurrence, causes, consequences. Springer, Berlin
MacKintosh C, Beattie KA, Klumpp S, Cohen P, Codd GA (1990) FEBS Lett 264:187–192
Fujiki H, Suganuma M, Yoshizawa S, Nishiwaki S, Winyar B, Sugimura T (1991) Environ Health Perspect 93:211–214
Xing Y, Xu Y, Chen Y, Jeffrey PD, Chao Y, Lin Z, Li Z, Strack S, Stock JB, Shi Y (2006) Cell 127:341–353
Kirkland D, Aardema M, Henderson L, Müller L (2005) Mutat Res 584:1–256
Kirkland D, Aardema M, Müller L, Makoto H (2006) Mutat Res 608:29–42
Dietrich D, Hoeger S (2005) Toxicol Appl Pharmacol 203:273–289
Wiegand C, Pflugmacher S (2005) Toxicol Appl Pharmacol 203:201–218
García C, Barriga A, Díaz JC, Lagos M, Lagos N (2010) Toxicon (in press)
EMEA (2006) EMEA guideline on the limits of genotoxic impurities. http://www.emea.europa.eu/pdfs/human/swp/519902en.pdf
Eichenbaum G, Johnson M, Kirkland D, O'Neill P, Stellar S, Bielawne J, DeWire R, Areia D, Bryant S, Weiner S, Desai-Krieger D, Guzzie-Peck P, Evans DC, Tonelli A (2009) Regul Toxicol Pharmacol 55:33–42
Speit G, Autrup H, Crebelli R, Henderson L, Kirsch-Volders M, Madle S, Parry JM, Sarrif AM, Vrijhof H (2000) Mutat Res 464:149–153
Neumann HG (2009) Crit Rev Toxicol 39:449–461
Elhajouji A, Tibaldi F, Kirsch-Volders M (1997) Mutagenesis 12:133–140
Kirsch-Volders M, Vanhauwaert A, Eichenlaub-Ritter U, Decordier I (2003) Toxicol Lett 140–141:63–74
Kirsch-Volders M, Gonzalez L, Carmichael P, Kirkland D (2009) Mutat Res 678:72–75
Organisation for Economic Co-operation and Development () OECD guidelines for the testing of chemicals. Section 4: health effects. http://oberon.sourceoecd.org/vl=430571/cl=15/nw=1/rpsv/cw/vhosts/oecdjournals/1607310x/v1n4/contp1-1.htm
Arlt VM, Frei E, Schmeiser HH (2007) Mutagenesis 22:83–88
Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YF (2000) Environ Mol Mutagen 35:206–221
Hartmann A, Schumacher M, Plappert-Helbig U, Lowe P, Suter W, Mueller L (2004) Mutagenesis 19:51–59
Collins AR (2009) Mutat Res Rev Mut Res 681:24–32
Speit G, Hartmann A (2005) Meth Mol Biol 291:85–95
Hartmann A, Agurell E, Beevers C, Brendler-Schwaab S, Burlinson B, Clay P, Collins A, Smith A, Speit G, Thybaud V, Tice RR (2003) Mutagenesis 18:45–51
Madle S, Dean SW, Andrae U, Brambilla G, Burlinson B, Doolittle DJ, Furihata C, Hertner T, McQueen CA, Mori H (1994) Mutat Res 312:263–285
Ames BN (1971) In: Hollaender A (ed) Chemical mutagens: principles and methods for their detection, vol 1. Plenum, New York, pp 267–282
Ames BN, Lee F, Durston W (1973) Proc Natl Acad Sci USA 70:782–786
Mortelmans K, Riccio ES (2000) Mutat Res Fundam Mol Mech Mutagen 455:61–66
Kamber M, Flückiger-Isler S, Engelhardt G, Jaeckh R, Zeiger E (2009) Mutagenesis 24:359–366
Moore MM, Honma M, Clements J, Awogi T, Bolcsfoldi G, Cole J, Gollapudi B, Harrington-Brock K, Mitchell A, Muster W, Myhr B, O'Donovan M, Ouldelhkim MC, San R, Shimada H, Stankowski LF Jr (2000) Environ Mol Mutagen 35:185–190
Moore MM, Honma M, Clements J, Harrington-Brock K, Awogi T, Bolcsfoldi G, Cifone M, Collard D, Fellows M, Flanders K, Gollapudi B, Jenkinson P, Kirby P, Kirchner S, Kraycer J, McEnaney S, Muster W, Myhr B, O'Donovan M, Oliver J, Ouldelhkim MC, Pant K, Preston R, Riach C, San R, Shimada H, Stankowski LF Jr (2002) Environ Mol Mutagen 40:292–299
Moore MM, Honma M, Clements J, Bolcsfoldi G, Cifone M, Delongchamp R, Fellows M, Gollapudi B, Jenkinson P, Kirby P, Kirchner S, Muster W, Myhr B, O'Donovan M, Oliver J, Omori T, Ouldelhkim MC, Pant K, Preston R, Riach C, San R, Stankowski LF Jr, Thakur A, Wakuri S, Yoshimura I (2003) Mutat Res 540:127–140
Moore MM, Honma M, Clements J, Bolcsfoldi G, Burlinson B, Cifone M, Clarke J, Delongchamp R, Durward R, Fellows M, Gollapudi B, Hou S, Jenkinson P, Lloyd M, Majeska J, Myhr B, O’Donovan M, Omori T, Riach C, San R, Stankowski LF Jr, Thakur AK, Van Goethem F, Wakuri S, Yoshimura I (2006) Environ Mol Mutagen 47:1–5
Moore MM, Honma M, Clements J, Bolcsfoldi G, Burlinson B, Cifone M, Clarke J, Clay P, Doppalapudi R, Fellows M, Gollapudi B, Hou S, Jenkinson P, Muster W, Pant K, Kidd DA, Lorge E, Lloyd M, Myhr B, O’Donovan M, Riach C, Stankowski LF Jr, Thakur AK, Van Goethem F (2007) Mutat Res 627:36–40
Wahnschaffe U, Bitsch A, Kielhorn J, Mangelsdorf I (2005) J Carcinog 4:4–12
Thybaud V, Dean S, Nohmi T, de Boer J, Douglas GR, Glickman BW, Gorelick NJ, Heddle JA, Heflich RH, Lambert I, Martus HJ, Mirsalis JC, Suzuki T, Yajima N (2003) Mutat Res 540:141–151
Nohmi T, Suzuki T, Masumura K (2000) Mutat Res 455:191–215
Lambert IB, Singer TM, Boucher SE, Douglas GR (2005) Mutat Res 590:1–280
Corvi R, Albertini S, Hartung T, Hoffmann S, Maurici D, Pfuhler S, van Benthem J, Vanparys P (2008) Mutagenesis 23:271–283
Fenech M (2000) Mutat Res 455:81–95
Fenech M (2007) Nat Protoc 2:1084–1104
Frieauff W, Pötter-Locher F, Cordier A, Suter W (1998) Mutat Res 413:57–68
Decordier I, Papine A, Plas G, Roesems S, Vande Loock K, Moreno-Palomo J, Cemeli E, Anderson D, Fucic A, Marcos R, Soussaline F, Kirsch-Volders M (2009) Mutagenesis 24:85–93
Dertinger S, Torous D, Hall N, Tometsko C (2003) Curr Protoc Cytom 7:Unit 7.21
Dertinger SD, Bishop ME, McNamee JP, Hayashi M, Suzuki T, Asano N, Nakajima M, Saito J, Moore M, Torous DK, Macgregor JT (2006) Toxicol Sci 94:83–91
Wilson DM, Thompson LH (2007) Mutat Res 616:11–23
Connell JR (2006) Int J Cancer 24(4):485–489
Anderson BE, Zeiger E, Shelby MD, Resnick MA, Gulati DK, Ivett JL, Loveday KS (2008) Environ Mol Mutagen 16:55–137
Schuler M, Rupa DS, Eastmond DA (1997) Mutat Res 392:81–95
Kirsch-Volders M, Vanhauwaert A, De Boeck M, Decordier I (2002) Mutat Res 504:137–148
Kirsch-Volders M, Elhajouji A, Cundari E, Van Hummelen P (1997) Mutat Res 392:19–30
Parry JM, Parry EM (2006) Mutat Res 607:5–8
Ku WW, Bigger A, Brambilla G, Glatt H, Gocke E, Guzzie PJ, Hakura A, Honma M, Martus HJ, Obach RS, Roberts S (2007) Mutat Res 627:59–77
Honma M, Hayashi M, Shimada H, Tanaka N, Wakuri S, Awogi T, Yamamoto KI, Kodani N, Nishi Y, Nakadate M, Sofuni T (1999) Mutagenesis 14:5–22
Nesslany F, Marzin D (1999) Mutagenesis 14:403–410
Portela-Cubillo F, Scott JS, Walton JC (2008) J Org Chem 73:5558–5565
Debdab M, Renault S, Lozach O, Meijer L, Paquin L, Carreaux F, Bazureau JP (2010) Eur J Med Chem (in press)
Snyder RD, Smith MD (2005) Drug Discov Today 10:1119–1124
Veith GD (2006) ALTEX 23(Suppl):369–372
Custer LL, Sweder KS (2008) Curr Drug Metab 9:978–985
Fowler S, Zhang H (2008) AAPS J 10:410–424
Cimino MC (2006) Environ Mol Mutagen 47:362–390
Food and Drug Administration () Genotoxicity testing and data interpretation for pharmaceuticals intended for human use. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm074931.pdf
Meintieres S, Nesslany F, Pallardy M, Marzin D (2003) Environ Mol Mutagen 41:260–269
Parry J (2000) Guidance on a strategy for testing of chemicals for mutagenicity. Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment, London
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fessard, V., Le Hégarat, L. A strategy to study genotoxicity: application to aquatic toxins, limits and solutions. Anal Bioanal Chem 397, 1715–1722 (2010). https://doi.org/10.1007/s00216-010-3699-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-010-3699-3